Research
Biomarkers for Precision Oncology : A. Thierry

activities

Our team’s objective is to discover predictive and prognostic biomarkers for use in personalized (‘precision’) medicine in oncology. Fundamental and translational projects are implemented in integrative and clinically pertinent research.

More

MAIN PUBLICATIONS

Mirandola A, Kudriavtsev A, Cofre Muñoz C, Navarro R, Macagno M, Daoud S, Sanchez C, Pastor B, Pisareva E, Marin M, Ruiz J, Piris A, Rodriguez A, Gonzalez N, Vivancos A, Quarà V, Mellano A, Borghi F, Corti G, Marchiò C, Sapino A, Bartolini A, Crisafulli G, Bardelli A, Di Maio M, Lossaint G, Frayssinoux F, Crapez E, Ychou M, Soler R, Fenocchio E, Fernandez Calotti P, Mazard T, Vivas C, Elez E, Di Nicolantonio F, Thierry A Post-surgery sequelae unrelated to disease progression and chemotherapy revealed in follow-up of patients with stage III colon cancer. EBioMedicine. 2024;108. doi:10.1016/j.ebiom.2024.105352

Thierry A Circulating DNA fragmentomics and cancer screening. Cell Genom. 2023;3(1):100242. doi:10.1016/j.xgen.2022.100242

Pisareva E, Mihalovi?ová L, Pastor B, Kudriavtsev A, Mirandola A, Mazard T, Maus U, Ostermann L, Weinmann-Menke J, Neuberger E, Simon P, Thierry A Neutrophil extracellular traps have auto-catabolic activity and produce mononucleosome-associated circulating DNA. Genome Med. 2022;14(1):135. doi:10.1186/s13073-022-01125-8

Al Amir Dache Z, Otandault A, Tanos R, Pastor B, Meddeb R, Sanchez C, Arena G, Lasorsa L, Bennett A, Grange T, El Messaoudi S, Mazard T, Thierry A Blood contains circulating cell-free respiratory competent mitochondria. FASEB J.. Jan 19, 2020. doi:10.1096/fj.201901917RR

Prévostel C, Blache P The dose-dependent effect of SOX9 and its incidence in colorectal cancer. Eur. J. Cancer. 2017;86. doi:10.1016/j.ejca.2017.08.037


Team

Team Leader  Alain Thierry

 

Institut de Recherche en
Cancérologie de Montpellier
Campus Val d’Aurelle
34298 Montpellier cedex 5

Tél. : 33 (0)4 67 61 30 66 / 06 63 82 19 94

 

alain.thierry@inserm.fr

Partners / Funding


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés